Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan W Friedberg

Showing results (51-60 of 300) with videos related to

Pageof 30
Sort By:
Current Oncology Reports|August 19, 2008
Beyond rituximab: the future of monoclonal antibodies in B-cell non-Hodgkin lymphomaManzurul A Sikder, Jonathan W Friedberg
The Oncologist|April 4, 2009
Salvage therapy in Hodgkin's lymphomaJason H Mendler, Jonathan W Friedberg
Current Hematologic Malignancy Reports|May 4, 2010
Gemcitabine and other new cytotoxic drugs: will any find their way into primary therapy?David W Dougherty, Jonathan W Friedberg
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2022
Introducing Clinical Trial UpdatesKathy D Miller, Jonathan W Friedberg
Seminars in Hematology|April 3, 2008
Monoclonal antibodies in lymphoma: the first decadeBrian K Link, Jonathan W Friedberg
Future Oncology (London, England)|May 13, 2015
Advancing radioimmunotherapy and its future role in non-Hodgkin lymphomaPatrick M Reagan, Jonathan W Friedberg
Current Treatment Options in Oncology|June 3, 2015
Follicular lymphoma: first-line treatment without chemotherapy for follicular lymphomaPatrick M Reagan, Jonathan W Friedberg
Cancer Treatment and Research|May 18, 2006
Diffuse large B-cell NHLJonathan W Friedberg, Richard I Fisher
Hematology. American Society of Hematology. Education Program|December 17, 2008
Burkitt lymphoma in adultsArchibald S Perkins, Jonathan W Friedberg
Leukemia & Lymphoma|May 27, 2011
Getting to the heart of the problem in treating diffuse large B-cell lymphomaPaul M Barr, Jonathan W Friedberg
Pageof 30

Showing results (51-60 of 300) with videos related to

Sort By:
Pageof 30
Current Oncology Reports|August 19, 2008
Beyond rituximab: the future of monoclonal antibodies in B-cell non-Hodgkin lymphomaManzurul A Sikder, Jonathan W Friedberg
The Oncologist|April 4, 2009
Salvage therapy in Hodgkin's lymphomaJason H Mendler, Jonathan W Friedberg
Current Hematologic Malignancy Reports|May 4, 2010
Gemcitabine and other new cytotoxic drugs: will any find their way into primary therapy?David W Dougherty, Jonathan W Friedberg
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2022
Introducing Clinical Trial UpdatesKathy D Miller, Jonathan W Friedberg
Seminars in Hematology|April 3, 2008
Monoclonal antibodies in lymphoma: the first decadeBrian K Link, Jonathan W Friedberg
Future Oncology (London, England)|May 13, 2015
Advancing radioimmunotherapy and its future role in non-Hodgkin lymphomaPatrick M Reagan, Jonathan W Friedberg
Current Treatment Options in Oncology|June 3, 2015
Follicular lymphoma: first-line treatment without chemotherapy for follicular lymphomaPatrick M Reagan, Jonathan W Friedberg
Cancer Treatment and Research|May 18, 2006
Diffuse large B-cell NHLJonathan W Friedberg, Richard I Fisher
Hematology. American Society of Hematology. Education Program|December 17, 2008
Burkitt lymphoma in adultsArchibald S Perkins, Jonathan W Friedberg
Leukemia & Lymphoma|May 27, 2011
Getting to the heart of the problem in treating diffuse large B-cell lymphomaPaul M Barr, Jonathan W Friedberg
Pageof 30